A Panel of Three Markers Hyper- And Hypomethylated in Urine Sediments Accurately Predicts Bladder Cancer Recurrence

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-2637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Detection of Bladder Cancer Using Novel DNA Methylation Biomarkers in Urine Sediments

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2011English

Methylation Markers for Urine-Based Detection of Bladder Cancer: The Next Generation of Urinary Markers for Diagnosis and Surveillance of Bladder Cancer

Advances in Urology
GynecologyUrologyObstetrics
2012English

A Panel of DNA Methylation Markers for the Detection of Prostate Cancer From FV and DRE Urine DNA

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2018English

Urine Telomerase for Diagnosis and Surveillance of Bladder Cancer

Advances in Urology
GynecologyUrologyObstetrics
2012English

Urinary Markers in Bladder Cancer: An Update

Frontiers in Oncology
Cancer ResearchOncology
2018English

Fluorescence Detection of Bladder Cancer Using Urine Cytology

International Journal of Oncology
Cancer ResearchOncology
2007English

Random Biopsy and Recurrence Risk in Patients With Bladder Cancer

Japanese Journal of Urology
Urology
1996English

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

A Random Forest Classifier Predicts Recurrence Risk in Patients With Ovarian Cancer

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy